I want to bring in Dr John Brownstein, now chief innovation officer of Boston's Children's Hospital.

Dr Brownstein thanks so much for joining us course.

So the group tested today has four healthy volunteers will be monitored over a period of time.

Can you explain what this process will look like and how those people will be tracked, right?

So worth the early phases of this vaccine trial.

Right?

So Phase one, meaning small group of people are gonna be evaluating for how they react, how well they do, if potentially, there's some efficacy.

Also Summerlee information about safety.

But we have to remember this is a really small trial, that it will eventually lead to Maur participants.

But we're still so early and evaluating this vaccine, it's incredibly exciting.

Vaccines are a big backbone of public health, and we should be striving.

But again, we're still many months out from having something that we can really deployed to the public.

It's still incredibly early.

I hear you saying many months out.

But if these tests proved to be successful, how soon could the country expect a roll out of the vaccine?

So the vaccine that we're looking at is incredibly modern type of vaccine.

It's based on our in A.

It's not the traditional way of building a vaccine, so we're going as fast as humanly possible.

But the problem is that we're still, you know, with phase 23 we're still gonna have to test the efficacy, but also the safety.

It's so important that we get this vaccine right, and so that's gonna lead us to probably a year to 18 months before we can really have this vaccine well past especially the first wave of this epidemic as it's unfolding across the country.

And we know that states are now taking testing into their own hands.

Is there a benefit to spreading out the resource is, or should there just be one overarching test?

No, I mean, I think the reality is we need outlaw hands on deck on testing.

Of course, there's the commercial labs.

There's hospitals.

Many people are now deploying tests.

We need to have a direct understanding of what's happening in communities across the country so that we can really deploy.

The resource is properly.

So No, I think the idea is to have a diverse number of groups sort of working towards this as possible.

And last question for you.

As people start to work from home and continue to wash their hands, what else can people do to try to flatten the curve?

Right.

So the idea is all about social distancing, right?

So limiting your grouping with other people staying at home.

Of course, we're gonna depend on those that are recovering, right?

So those that actually had the virus and recovered they can play an incredible role.

And actually being active members of society is other people are quarantined inside, so we'll have to remember those recovered as well.

I mean, the end of the day, we're trying to protect our house systems from getting completely overrun so we can take care of the sickest patients.

All right, Dr.

John Brownstein.

Thank you so much for joining us.

We appreciate that.

Hi, everyone.

George Stephanopoulos here.

Thanks for checking on ABC News YouTube channel.

If you'd like to get more video show highlights and watch live event coverage, click on the right over here to subscribe to our channel.

And don't forget the download.

The ABC News After breaking news alerts Thanks for watching.